Four consecutive ENIW contracts (2015-2021) delivering innovation management services to SMEs across England, Northern Ireland and Wales, with growing budgets each cycle.
INVENTYA LTD
UK innovation consultancy delivering SME growth, commercialisation, and internationalisation services through the Enterprise Europe Network.
Their core work
Inventya is an innovation consultancy based in Warrington, UK, that helps SMEs grow through structured innovation management, commercialisation support, and internationalisation services. Their core work under the ENIW programme involves delivering hands-on advisory services to small businesses across England, Northern Ireland, and Wales — helping them scale up, find investment, and access global markets. They also contribute commercialisation and knowledge transfer expertise to research training networks in medical physics and fundamental physics.
What they specialise in
ENIW keywords consistently emphasise commercialisation, internationalisation, investment readiness, and connections to global markets and partners.
Participated in NEVERMIND (2016-2020), a research project on neurobehavioural modelling of depressive symptoms, receiving EUR 428K — likely providing exploitation and commercialisation planning.
Third-party contributor to OMA (medical accelerators) and AVA (antimatter physics) Marie Curie training networks, likely supporting researcher career development and technology transfer skills.
How they've shifted over time
Inventya's early H2020 involvement (2015-2017) was more diverse, including third-party roles in advanced physics research training networks (particle beam therapy, antimatter physics) alongside their first ENIW innovation support contract. From 2017 onward, they consolidated heavily around their core SME innovation management work, winning progressively larger ENIW contracts — their funding grew from EUR 99K in 2015 to EUR 672K in 2020. This trajectory shows a company that tested adjacent domains early on, then doubled down on what they do best: helping businesses commercialise and scale.
Inventya is scaling its core innovation advisory business with increasing contract sizes, making them a strong delivery partner for any programme requiring SME support services across the UK.
How they like to work
Inventya has never coordinated an H2020 project but is a reliable participant and delivery partner, especially in service-oriented Coordination and Support Actions. With 67 unique consortium partners across 14 countries, they operate in broad networks but their recurring ENIW involvement suggests they have established trusted relationships with the Enterprise Europe Network ecosystem. They are a dependable execution partner rather than a project leader — ideal for consortia needing embedded innovation support services.
Inventya has worked with 67 different consortium partners across 14 countries, indicating a well-connected European network despite being a UK-based SME. Their geographic spread likely reflects both the multinational ENIW consortia and the pan-European research training networks they contributed to.
What sets them apart
Inventya combines practical, hands-on SME growth advisory with experience inside EU research programmes — an unusual combination for a private consultancy. Their four consecutive ENIW contracts demonstrate proven delivery capability and trusted-partner status within the Enterprise Europe Network. For consortium builders, they bring ready-made infrastructure for innovation management work packages, dissemination, and exploitation planning.
Highlights from their portfolio
- ENIWFour consecutive contracts (2015-2021) with funding growing from EUR 99K to EUR 672K, demonstrating sustained trust and expanding delivery scope in SME innovation services.
- NEVERMINDLargest single research project participation (EUR 428K) in digital health — shows capability to contribute commercialisation expertise to clinical research consortia.
- OMAThird-party role in a Marie Curie training network on medical accelerators — an unusual cross-sector contribution connecting innovation management with advanced medical physics.